Neurocrine Biosciences NBIX Investment income and other, net
Investment income and other, net at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Neurocrine Biosciences in its filing.
Tagged under the XBRL concept nbix:InvestmentIncomeAndOtherNet.
The official record: Neurocrine Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neurocrine Biosciences's investment income and other, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neurocrine Biosciences's investment income and other, net?
- Neurocrine Biosciences (NBIX) reported investment income and other, net of $28.1M in Q1 2026.
- How has Neurocrine Biosciences's investment income and other, net changed year-over-year?
- Neurocrine Biosciences's investment income and other, net increased by 29.5% year-over-year, from $21.7M to $28.1M.
- What is the long-term trend for Neurocrine Biosciences's investment income and other, net?
- Over 4 years (2021 to 2025), Neurocrine Biosciences's investment income and other, net has grown at a 120.8% compound annual growth rate (CAGR), from $3.8M to $90.3M.
- What does investment income and other, net mean?
- Investment income and other, net, includes interest earned on cash and cash equivalents, as well as other miscellaneous non-operating income or expenses. This represents the return on the company's idle cash balances and other peripheral financial activities. It is a secondary source of income that supports the overall financial position.